The role of leptin in osteoarthritis: from pathogenesis to clinical implications
Gabriele Ricciardi1,2,#,*, Mariagiovanna Ballato1,#, Gabriele Di Carlo3, Domenico Donadio1,2,4,5, Emanuela Germanà1, Flavio Corpina2,6,7, Carmela Lipari2,6,8, Guido Fadda9, Danilo Leonetti3, Biagio Zampogna3,4,5, Marco Ferlazzo2, Maurizio Martini9,*
European Cytokine Network, Vol.37, No.3, pp. 169-191, 2026, DOI:10.32604/ecn.2026.084855
- 28 September 2026
Abstract Osteoarthritis (OA) is increasingly recognized as a multifactorial disease in which metabolic dysfunction and chronic low-grade inflammation contribute to joint degeneration. Among the mediators involved, leptin has emerged as a key adipokine linking obesity, aging, and inflammatory processes to OA development and progression. However, despite growing evidence, its role remains incompletely understood, and a comprehensive framework integrating leptin-related mechanisms across different joint tissues is still lacking. This review provides an updated overview of the role of leptin in OA pathogenesis, focusing on its effects on cartilage, synovium, subchondral bone, and the infrapatellar fat pad. We… More >